About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6261 record(s)
Req # A-2020-001374
For the period 2015 to April 19, 2021, and in relation to natural health product brand names containing the phrase “glucosamine sulfate” or “glucosamine sulphate”, with license holders named WN Pharmaceuticals Ltd, Natural Factors Nutritional Products Limited, or Jamieson Laboratories Inc., the following documents. All product licences, and the specifications to which the natural health product will comply. All applications for a product licence, correspondences with respect to those applications, and the attestations by the applicants that the product will be manufactured and distributed in accordance with good manufacturing practices. All testing done of the product, and correspondences made in relation to the testing of the product. All correspondences between the Minister and a licensee, manufacturer, importer or distributer to stop their sale of the product. All correspondences in relation to labelling and packaging of the product; and all complaints of non-compliance in respect of the product. For the period May 6, 2004 to April 19, 2021, all monographs of “glucosamine sulfate” and “glucosamine hydrochloride”Organization: Health Canada
March 2024
Req # A-2021-001830
A summary of the costs incurred to develop, advertise, and run the COVID Alert App program mentioned in this news story: https://globalnews.ca/news/8478550/attempts-improve-covid-alert-stall-lack-of-interest-provinces/. Records from the start of the program to January 21, 2022.Organization: Health Canada
March 2024
Req # A-2021-001944
An analysis of the hazards present at the site and quantify any potential risk of historical exposusres, Canada Training Centre in Kemptville Ontario by Bluemetric Environmental Inc. A copy of this report as well as all all communications between the Royal Canadian Mounted Police (RCMP) and Health Canada regarding their response to the report.Organization: Health Canada
March 2024
Req # A-2022-000619
Any document containing information on the oversight or monitoring conducted by Health Canada with respect to personal cannabis cultivation, and any statistics, data or information of any nature or kind compiled by Health Canada or in the possession of Health Canada with respect to the presence of risks associated with growing cannabis on one’s dwelling-house. Any document containing information of any nature or kind compiled by Health Canada or in the possession of Health Canada with respect to licenses. Dated from October 17, 2018 to August 11, 2022.Organization: Health Canada
March 2024
Req # A-2022-000704
All correspondence between Health Canada officials and Dr. Daniel Myran from January 1, 2022 and August 26, 2022 regarding Dr. Daniel Myran.Organization: Health Canada
March 2024
Req # A-2022-000798
Health Canada issued a Request for Information (RFI) to Industry regarding the Canadian Dental Care Plan (CDCP) currently in development. Interested suppliers were to provide a response summited through the Electronic Procurement Solution (EPS). All RFI responses Health Canada received between when the RFI was issued and August 22, 2022.Organization: Health Canada
March 2024
Req # A-2022-001043
Relating to the investigation of the "New Brunswick neurological syndrome of unknown cause", all documents and all other correspondence from anyone within the department and/or under its influence or control between January 01, 2017 and October 31, 2022.Organization: Health Canada
March 2024
Req # A-2022-001122
All records that involve Egale Canada Human Rights Trust and Egale Canada, from December 2019 to December 2022.Organization: Health Canada
March 2024
Req # A-2022-001389
The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Pratices (GVP) inspection of the Johnson & Johnson facility (Site B) located on McNabb St, Markham, Ontario starting around 7 February 2022. Reference Number 502933.Organization: Health Canada
March 2024
Req # A-2022-001508
Any briefing notes, discussion papers, reports or presentations done in 2022 on best practices of the healthcare systems of other countries compared to those in Canada.Organization: Health Canada
March 2024